Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AMTI | Common Stock | Other | -2.15M | -25.78% | 6.19M | Dec 27, 2023 | See Footnote | F1, F2, F6, F10 | ||
transaction | AMTI | Common Stock | Other | -3.39M | -54.86% | 2.79M | Dec 27, 2023 | See Footnote | F1, F3, F7, F10 | ||
transaction | AMTI | Common Stock | Other | -2.5M | -89.5% | 293K | Dec 27, 2023 | See Footnote | F1, F4, F8, F10 | ||
transaction | AMTI | Common Stock | Other | -293K | -100% | 0 | Dec 27, 2023 | See Footnote | F1, F5, F9, F10 |
EPIQ Capital Group, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | On December 27, 2023, Applied Molecular Transport Inc. ("AMTI") completed the previously announced strategic combination contemplated by that certain Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc. ("Cyclo"), Cameo Merger Sub, Inc., a wholly owned subsidiary of Cyclo ("Merger Sub"), and AMTI, providing for the merger of Merger Sub with and into AMTI, with AMTI surviving the merger as a wholly-owned subsidiary of Cyclo (the "Merger"). At the Merger closing, each share of common stock of AMTI reported as disposed of on this Form 4 was automatically converted into the right to receive 0.1331 shares of common stock of Cyclo (the "Transaction Consideration"). Refer to the AMTI Form 8-K filing with the Securities and Exchange Commission dated December 27, 2023 for additional information concerning the Merger. |
F2 | EPQ LLC, AMT PS is the direct owner of these shares. |
F3 | EPQ LLC, AMTB PS is the direct owner of these shares. |
F4 | EPQ LLC, AMTC PS is the direct owner of these shares. |
F5 | Chad Boeding is the owner of these shares through a trust that he controls. |
F6 | Upon consummation of the Merger, EPQ LLC, AMT PS received Transaction Consideration of 286,071 shares of Cyclo common stock. |
F7 | Upon consummation of the Merger, EPQ LLC, AMTB PS received Transaction Consideration of 451,868 shares of Cyclo common stock. |
F8 | Upon consummation of the Merger, EPQ LLC, AMTC PS received Transaction Consideration of 332,750 shares of Cyclo common stock. |
F9 | Upon consummation of the Merger, Chad Boeding received Transaction Consideration of 39,036 shares of Cyclo common stock. |
F10 | EPIQ Capital Group, LLC ("EPIQ") is the managing member of EPQ LLC, AMT PS, EPQ LLC, AMTB PS, and EPQ LLC, AMTC PS (the "EPQ Funds"). Chad Boeding is the Manager of EPIQ. |
Each of EPIQ, the EPQ Funds, and Mr. Boeding disclaims beneficial ownership of the shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.